SRI international:1110101 [22-000620]
Ended Awarded Last action
- Contract number
- 75N95022F00001
- Awardee
-
Sri International UEI SRG2J1WS9X63
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,672,813
Award facts
- Contract value 100% obligated
- $1,672,813.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Menlo Park, CA 94025, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Change Order | $44,676 | |
| Change Order | $17,430 | |
| Change Order | $11,596 | |
| Change Order | $272,115 | |
| Change Order | $0 | |
| Other Administrative Action | -$3,000 | |
| Original award | $1,329,996 |
Show all 14
About this award
SRI International, a nonprofit research and development organization, was awarded a delivery order valued at $1.67M under the National Institute on Drug Abuse's (NIDA) indefinite delivery/indefinite quantity (IDIQ) contract HHSN271201800019I. Task Order 75N95022F00001, titled "GLP Interaction Safety Studies in Rats and Dogs," runs from November 17, 2021 through February 28, 2026 and focuses on toxicological evaluations of potential medications. The contract employs a cost-plus-fixed-fee pricing structure and will be performed at SRI International's facility in Menlo Park, California. No small business set-aside was applied to this award.
This task order supports NIDA's mission to advance drug abuse research and treatment development by conducting rigorous preclinical toxicological safety assessments under Good Laboratory Practice (GLP) standards. SRI International's multidisciplinary research capabilities position it well to conduct comprehensive interaction safety studies using animal models, which are critical for evaluating the safety profiles of potential therapeutic medications before advancement to human trials. The work falls within SRI's established track record of providing specialized toxicology and safety evaluation services to federal health and research agencies.
Quick answers
Who was awarded contract 75N95022F00001?
75N95022F00001 was awarded to Sri International by National Institute on Drug Abuse (National Institutes of Health) on November 17, 2021.
How much is contract 75N95022F00001 worth?
The government has obligated $1,672,813 on 75N95022F00001.
Is contract 75N95022F00001 an order under another contract?
Yes. 75N95022F00001 is a delivery order under 75N95018G00019, a basic ordering agreement.
Was contract 75N95022F00001 competed?
The extent of competition for 75N95022F00001 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award